VANDA PHARMACEUTICALS INC. Income Tax Expense
VANDA PHARMACEUTICALS INC. (VNDA) reported Income Tax Expense of $129.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- VANDA PHARMACEUTICALS INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $129.00K.
- VANDA PHARMACEUTICALS INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $143.00K.
- VANDA PHARMACEUTICALS INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $103.19M.
- VANDA PHARMACEUTICALS INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$5.80M.
- VANDA PHARMACEUTICALS INC. income tax expense (benefit) for fiscal 2025 was $81.83M.
- VANDA PHARMACEUTICALS INC. income tax expense (benefit) for fiscal 2024 was -$4.02M, a 204.99% decline from fiscal 2023.
- VANDA PHARMACEUTICALS INC. income tax expense (benefit) for fiscal 2023 was $3.83M, a 23.78% decline from fiscal 2022.
- VANDA PHARMACEUTICALS INC. income tax expense (benefit) for fiscal 2022 was $5.03M, a 45.45% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $129.00K 10-Q · filed 2026-08-06 | $272.00K 10-Q · filed 2026-08-06 | $103.46M derived: sum of 3 quarters · filed 2026-08-06 | $97.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $143.00K 10-Q · filed 2026-05-07 | $103.33M derived: sum of 2 quarters · filed 2026-05-07 | $97.52M derived: sum of 3 quarters · filed 2026-05-07 | $89.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $103.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $97.38M derived: sum of 2 quarters · filed 2026-02-12 | $89.70M derived: sum of 3 quarters · filed 2026-08-06 | $81.83M 10-K · filed 2026-02-12 |
| 2025-09-30 | -$5.80M 10-Q · filed 2025-10-30 | -$13.48M derived: sum of 2 quarters · filed 2026-08-06 | -$21.36M 10-Q · filed 2025-10-30 | -$22.94M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$7.68M 10-Q · filed 2026-08-06 | -$15.55M 10-Q · filed 2026-08-06 | -$17.14M derived: sum of 3 quarters · filed 2026-08-06 | -$18.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$7.87M 10-Q · filed 2026-05-07 | -$9.46M derived: sum of 2 quarters · filed 2026-05-07 | -$10.38M derived: sum of 3 quarters · filed 2026-05-07 | -$11.38M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$2.50M derived: sum of 2 quarters · filed 2026-02-12 | -$3.50M derived: sum of 3 quarters · filed 2026-02-12 | -$4.02M 10-K · filed 2026-02-12 |
| 2024-09-30 | -$920.00K 10-Q · filed 2025-10-30 | -$1.92M derived: sum of 2 quarters · filed 2025-10-30 | -$2.44M 10-Q · filed 2025-10-30 | -$1.70M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | -$998.00K 10-Q · filed 2025-07-31 | -$1.52M 10-Q · filed 2025-07-31 | -$777.00K derived: sum of 3 quarters · filed 2026-02-12 | -$1.03M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | -$518.00K 10-Q · filed 2025-05-08 | $221.00K derived: sum of 2 quarters · filed 2026-02-12 | -$36.00K derived: sum of 3 quarters · filed 2026-02-12 | $1.04M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $739.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $482.00K derived: sum of 2 quarters · filed 2026-02-12 | $1.55M derived: sum of 3 quarters · filed 2026-02-12 | $3.83M 10-K · filed 2026-02-12 |
| 2023-09-30 | -$257.00K 10-Q · filed 2024-11-07 | $815.00K derived: sum of 2 quarters · filed 2024-11-07 | $3.09M 10-Q · filed 2024-11-07 | $5.84M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $1.07M 10-Q · filed 2024-08-01 | $3.35M 10-Q · filed 2024-08-01 | $6.10M derived: sum of 3 quarters · filed 2025-02-14 | $8.29M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $2.28M 10-Q · filed 2024-05-09 | $5.03M derived: sum of 2 quarters · filed 2025-02-14 | $7.22M derived: sum of 3 quarters · filed 2025-02-14 | $8.44M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $4.94M derived: sum of 2 quarters · filed 2025-02-14 | $6.16M derived: sum of 3 quarters · filed 2025-02-14 | $5.03M 10-K · filed 2025-02-14 |
| 2022-09-30 | $2.19M 10-Q · filed 2023-11-09 | $3.41M derived: sum of 2 quarters · filed 2023-11-09 | $2.27M 10-Q · filed 2023-11-09 | $3.81M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | $1.22M 10-Q · filed 2023-07-28 | $82.00K 10-Q · filed 2023-07-28 | $1.61M derived: sum of 3 quarters · filed 2024-02-08 | $4.57M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | -$1.13M 10-Q · filed 2023-05-03 | $398.00K derived: sum of 2 quarters · filed 2024-02-08 | $3.35M derived: sum of 3 quarters · filed 2024-02-08 | $6.30M derived: sum of 4 quarters · filed 2024-02-08 |
| 2021-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $4.48M derived: sum of 2 quarters · filed 2024-02-08 | $7.43M derived: sum of 3 quarters · filed 2024-02-08 | $9.21M 10-K · filed 2024-02-08 |
| 2021-09-30 | $2.95M 10-Q · filed 2022-11-03 | $5.90M derived: sum of 2 quarters · filed 2022-11-03 | $7.68M 10-Q · filed 2022-11-03 | $10.41M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $2.95M 10-Q · filed 2022-08-04 | $4.73M 10-Q · filed 2022-08-04 | $7.46M derived: sum of 3 quarters · filed 2023-02-09 | $9.92M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $1.78M 10-Q · filed 2022-05-06 | $4.51M derived: sum of 2 quarters · filed 2023-02-09 | $6.97M derived: sum of 3 quarters · filed 2023-02-09 | $9.34M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $5.19M derived: sum of 2 quarters · filed 2023-02-09 | $7.56M derived: sum of 3 quarters · filed 2023-02-09 | $8.32M 10-K · filed 2023-02-09 |
| 2020-09-30 | $2.45M 10-Q · filed 2021-11-04 | $4.83M derived: sum of 2 quarters · filed 2021-11-04 | $5.58M 10-Q · filed 2021-11-04 | $7.18M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $2.38M 10-Q · filed 2021-07-29 | $3.13M 10-Q · filed 2021-07-29 | $4.72M derived: sum of 3 quarters · filed 2022-02-24 | -$83.42M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $755.00K 10-Q · filed 2021-05-06 | $2.35M derived: sum of 2 quarters · filed 2022-02-24 | -$85.80M derived: sum of 3 quarters · filed 2022-02-24 | -$85.78M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$86.55M derived: sum of 2 quarters · filed 2022-02-24 | -$86.53M derived: sum of 3 quarters · filed 2022-02-24 | -$86.53M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$88.15M 10-Q · filed 2020-10-29 | -$88.13M derived: sum of 2 quarters · filed 2020-10-29 | -$88.12M 10-Q · filed 2020-10-29 | -$88.16M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $18.00K 10-Q · filed 2020-08-06 | $28.00K 10-Q · filed 2020-08-06 | -$14.00K derived: sum of 3 quarters · filed 2021-02-11 | $78.00K derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $10.00K 10-Q · filed 2020-05-07 | -$32.00K derived: sum of 2 quarters · filed 2021-02-11 | $60.00K derived: sum of 3 quarters · filed 2021-02-11 | $150.00K derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $50.00K derived: sum of 2 quarters · filed 2021-02-11 | $140.00K derived: sum of 3 quarters · filed 2021-02-11 | $138.00K 10-K · filed 2021-02-11 |
| 2018-09-30 | $92.00K 10-Q · filed 2019-11-07 | $182.00K derived: sum of 2 quarters · filed 2019-11-07 | $180.00K 10-Q · filed 2019-11-07 | $267.00K derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $90.00K 10-Q · filed 2019-08-01 | $88.00K 10-Q · filed 2019-08-01 | $175.00K derived: sum of 3 quarters · filed 2020-02-26 | $198.00K derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$2.00K 10-Q · filed 2019-05-03 | $85.00K derived: sum of 2 quarters · filed 2020-02-26 | $108.00K derived: sum of 3 quarters · filed 2020-02-26 | $115.00K derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $110.00K derived: sum of 2 quarters · filed 2020-02-26 | $117.00K derived: sum of 3 quarters · filed 2020-02-26 | $136.00K 10-K · filed 2020-02-26 |
| 2017-09-30 | $23.00K 10-Q · filed 2018-11-07 | $30.00K derived: sum of 2 quarters · filed 2018-11-07 | $49.00K 10-Q · filed 2018-11-07 | $153.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $7.00K 10-Q · filed 2018-08-02 | $26.00K 10-Q · filed 2018-08-02 | $130.00K derived: sum of 3 quarters · filed 2019-02-19 | $130.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $19.00K 10-Q · filed 2018-05-02 | $123.00K derived: sum of 2 quarters · filed 2019-02-19 | $123.00K derived: sum of 3 quarters · filed 2019-02-19 | $123.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $104.00K derived: sum of 2 quarters · filed 2019-02-19 | $104.00K derived: sum of 3 quarters · filed 2019-02-19 | $104.00K 10-K · filed 2019-02-19 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 4 quarters · filed 2017-02-17 |
| 2016-06-30 | $0.00 10-Q · filed 2016-07-28 | $0.00 10-Q · filed 2016-07-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-17 | $0.00 derived: sum of 4 quarters · filed 2017-02-17 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-02-17 | $0.00 derived: sum of 3 quarters · filed 2017-02-17 | $0.00 derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $0.00 derived: sum of 2 quarters · filed 2017-02-17 | $0.00 derived: sum of 3 quarters · filed 2017-02-17 | $0.00 10-K · filed 2017-02-17 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-07-28 | $0.00 10-Q · filed 2016-07-28 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-17 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-12 | |||
| 2011-12-31 | -$286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$399.00K derived: sum of 2 quarters · filed 2014-02-25 | -$450.00K derived: sum of 3 quarters · filed 2014-02-25 | -$444.00K 10-K · filed 2014-02-25 |
| 2011-09-30 | -$113.00K 10-Q · filed 2012-11-08 | -$164.00K derived: sum of 2 quarters · filed 2012-11-08 | -$158.00K 10-Q · filed 2012-11-08 | -$1.42M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | -$51.00K 10-Q · filed 2012-08-03 | -$45.00K 10-Q · filed 2012-08-03 | -$1.31M derived: sum of 3 quarters · filed 2013-02-26 | -$3.60M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $6.00K 10-Q · filed 2012-05-09 | -$1.26M derived: sum of 2 quarters · filed 2013-02-26 | -$3.54M derived: sum of 3 quarters · filed 2013-02-26 | -$3.58M derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$3.55M derived: sum of 2 quarters · filed 2013-02-26 | -$3.59M derived: sum of 3 quarters · filed 2013-02-26 | $2.08M 10-K · filed 2013-02-26 |
| 2010-09-30 | -$2.29M 10-Q · filed 2011-11-07 | -$2.32M derived: sum of 2 quarters · filed 2011-11-07 | $3.34M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | -$37.00K 10-Q · filed 2011-08-05 | $5.63M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |